Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Oncol Nurs Forum. 2014 Nov 1;41(6):E313–E325. doi: 10.1188/14.ONF.E313-E325

Table 3.

Comparison of T0 Characteristics of AIM Study Participants Included and Not Included in the APOE Analysis (N = 366)

Characteristic Included (n = 128)
Not Included (n = 238)
pa
SD SD
Age (years) 59.31 5.699 60.66 6.432 0.048*

Years of education 15.22 3.157 14.55 2.66 0.032*

Estimated intelligenceb 110.25 9.184 108.33 9.149 0.057

Depressionc 4.8 5.161 6.1 6.608 0.055

Anxietyd 7.64 5.698 7.59 5.784 0.931

Fatiguee 5.2 5.77 5.67 5.575 0.456

Painf 1.25 1.98 1.51 2.292 0.262

Visual learning and memoryg 0.107 0.785 −0.1139 0.839 0.015*

Executive functiong 0.1316 0.598 0.0827 0.707 0.506

Verbal learning and memoryg −0.0591 0.843 −0.2237 0.809 0.068

Attentiong −0.1119 0.695 −0.2652 0.739 0.054

Psychomotor efficiencyg 0.0558 0.738 −0.1555 0.829 0.016*

Visuospatial abilityg −0.0902 1.018 −0.0847 0.899 0.958
*

p < 0.05

a

Independent t tests were used to compare means between AIM study participants included and not included in the APOE analysis.

b

National Adult Reading Test–Revised verbal IQ score

c

Beck Depression Inventory–II

d

Profile of Mood States tension/anxiety subscale

e

Profile of Mood States fatigue/inertia subscale

f

Brief Pain Inventory Pain Right Now score

g

Z score

AIM—Anastrozole Use in Menopausal Women; APOE—apolipoprotein E